Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018

This study uses Medicaid drug utilization data to describe reimbursement and market share of long-acting insulins before and after approval of new insulin products and to estimate savings associated with a “biosimilar” for insulin glargine approved in 2015.

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA
Autori principali: Hernandez, Inmaculada, Good, Chester B., Shrank, William H., Gellad, Walid F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2019
Soggetti:
Research Letter
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487544/
https://ncbi.nlm.nih.gov/pubmed/30907933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.2990
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi